Downloads: 1 | Views: 37 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1
Research Paper | Anaesthesiology | India | Volume 13 Issue 1, January 2024
Reconfiguring the Scope of Supraclavicular Brachial Plexus block with Bupivacaine along with the Adjuvants Dexmedetomidine, Clonidine or Fentanyl during the COVID-19 Pandemic: A Comparative, Double Blinded Study
Kavita Kadyan | Mridul M Panditrao [2]
Abstract: Introduction: In COVID- 19, preference of regional anaesthesia e.g., Supraclavicular brachial plexus was given over general anesthesia for upper limb surgeries. A search for an ideal adjuvant with bupivacaine and dexamethasone, ketamine has not yet been studied till now. Aim: To compare and evaluate the effects of Dexmedetomidine, Clonidine or Fentanyl as an adjuvant to Bupivacaine in USG guided Supraclavicular plexus block for the Upper limb surgeries. Materials and Method: A comparative, double-blind study. 90 cases of 18-65yrs, ASA grade I-II, were grouped into BD, BC, BF (30 each). Each group received 0.5% bupivacaine 20ml, inj Lignocaine (2%) with adr. 10ml, Inj Dexamethasone 4mg, inj Ketamine 30mg. 1mcg/kg dose of dexmedetomidine, clonidine and fentanyl. Total volume 35ml. Results: Age, weight, height, ASA, sex, SBP, DBP & HR were similar. Onset of sensory/motor block was earliest in BD than BC, and longest in BF. The duration of sensory/motor block and analgesia was longest in BD and shortest in BF.VAS Score was least in BD. and highest in BF. Conclusion: We conclude that dexmedetomidine provides a better edge due to fast onset, prolonged duration of sensory-motor blockade, better and longer pain relief with ability to achieve sedation without hemodynamic effects.
Keywords: Supraclavicular, bupivacaine, dexmedetomidine, clonidine, fentanyl
Edition: Volume 13 Issue 1, January 2024,
Pages: 471 - 481